Fly News Breaks for November 14, 2019
Nov 14, 2019 | 04:47 EDT
JPMorgan analyst Doug Anmuth downgraded Cardlytics to Neutral from Overweight with a $58 price target.
News For CDLX From the Last 2 Days
Apr 15, 2021 | 06:45 EDT
Wells Fargo analyst Timothy Willi upgraded Cardlytics to Overweight from Equal Weight with a $150 price target. Willi believes the recent underperformance has created a favorable entry point for shares, and sees several fundamental catalysts over the near to medium term, the analyst tells investors in a research note. The analyst views the risk/reward as favorable at current levels and the liquidity position as stable.